Keyphrases
Opioid Receptors
100%
Opioids
51%
μ-opioid Receptor
44%
δ Opioid Receptor
38%
G Protein-coupled Receptor
38%
Migraine
35%
Analgesic
34%
Morphine
33%
Kappa Opioid Receptor
28%
Nitroglycerin
25%
Arrestin
24%
Opioid Antagonist
24%
Wireless
22%
G Protein
22%
Optogenetics
21%
Prodrug
20%
Mitragynine
20%
Chronic Migraine
19%
Hyperalgesia
18%
Mouse Model
18%
Agonism
17%
Opioid Analgesics
17%
Analgesia
16%
Nucleus Accumbens
16%
Antinociception
16%
Respiratory Depression
15%
Adverse Effects
15%
Opioid-induced Hyperalgesia
15%
δ-Opioid Receptor Agonist
14%
SNC80
14%
Alkyl
13%
Splice Variant
13%
Knock-in Mouse Model
13%
Inverse Agonist
12%
Headache
12%
Trigeminal Ganglion
12%
Receptor Agonist
12%
Estrogen Receptor
11%
Kratom
11%
Pharmacology
11%
Exon 11
11%
Alkaloids
11%
Pharmacological Evaluation
11%
Synthetic Evaluation
11%
Receptor Activation
11%
Antinociceptive
10%
Nuclear Receptor
10%
Neural Probe
10%
Neuroscience
10%
Locus Coeruleus
10%
Molecular Mechanism
10%
Receptor Function
10%
Receptor Signaling
9%
Liver X Receptor
9%
Ventral Tegmental Area
9%
Allodynia
9%
Transmembrane Domain
9%
β-lactamase
9%
Selective Agonist
9%
125I
8%
Structure-based Design
8%
Biased Agonism
8%
Kratom Alkaloids
8%
Microfluidics
8%
MOR-1
8%
Rodents
8%
Inflammatory Pain
8%
Water Solubility
8%
5-HT2A Receptor
8%
Place Preference
8%
Chronic Pain
8%
Topical Delivery
8%
OPRM1
8%
Nanobody
7%
REV-ERB
7%
Wireless Optogenetics
7%
Neurovascular Coupling
7%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
7%
Drug Target
7%
Therapeutic Target
7%
Basolateral Amygdala
7%
Transmembrane
7%
Dynorphin
7%
Nociceptin
7%
Antitumor Activity
7%
Methyl
7%
Nucleus Accumbens Shell
7%
Nicotine
7%
13C NMR
7%
In Vivo Optogenetics
7%
Small Molecules
7%
Anxiety-like Behavior
7%
Alternative Splicing
7%
Cortical Spreading Depression
7%
Reward-related Behavior
6%
Chemotype
6%
Amides
6%
Theophylline
6%
Ex Vivo Human Skin
6%
Recent Advances
6%
Pharmacology, Toxicology and Pharmaceutical Science
Opiate Receptor
93%
Receptor
69%
Analgesic Agent
44%
Migraine
32%
G Protein Coupled Receptor
30%
Delta Opiate Receptor
26%
Side Effect
23%
Opiate Agonist
23%
μ-Opioid Receptor
22%
Morphine
22%
Retina S Antigen
20%
Guanine Nucleotide Binding Protein
20%
Delta Opiate Receptor Agonist
19%
Prodrug
19%
Mitragynine
19%
Kappa Opiate Receptor
18%
Diseases
17%
Mouse Model
14%
Hyperalgesia
13%
Respiration Depression
13%
Inverse Agonist
12%
Glyceryl Trinitrate
12%
Transformed Migraine
11%
Receptor Agonist
11%
Antinociception
10%
Cell Nucleus Receptor
10%
Liver X Receptor
9%
Narcotic Analgesic Agent
9%
Opiate
9%
Headache
9%
Structure Activity Relationship
8%
Duragesic
8%
Carboxamide
7%
Neoplasm
7%
Chronic Pain
7%
Theophylline
7%
Allodynia
7%
Drug Development
7%
Anti-Inflammatory Drug
7%
Iodine-125
6%
Drug Dependence
6%
Escherichia coli
6%
Knockout Mouse
6%
Kappa Opiate Receptor Agonist
6%
Penicillinase
6%
Natural Product
6%
Malignant Neoplasm
6%
Opioid-Induced Hyperalgesia
6%
Binding Site
6%
Carbonate Dehydratase
5%
Piperazinedione
5%
Hypophysis Adenylate Cyclase Activating Polypeptide
5%
Allosteric Modulator
5%
Posttraumatic Headache
5%
Inflammatory Pain
5%
Benzenesulfonamide
5%
Indole
5%
Naltrexamine
5%
Staphylococcus Aureus
5%
Carfentanil
5%
Inflammation
5%
Paracetamol
5%
Neuroscience
Receptor
80%
Migraine
46%
In Vivo
38%
Behavior (Neuroscience)
34%
Agonist
33%
Receptor Agonists
32%
Delta Opiate Receptor
31%
G Protein Coupled Receptor
30%
Hyperalgesia
29%
Optogenetics
25%
Morphine
25%
μ-Opioid Receptor
21%
Headache
20%
Kappa Opiate Receptor
18%
Nitroglycerin
16%
Nucleus Accumbens
15%
Trigeminal Ganglion
12%
Mitragynine
11%
Locus Coeruleus
10%
Neuroscience
10%
G Protein
10%
Retina S Antigen
9%
Ventral Tegmental Area
9%
5-HT2A Receptor
9%
In Vitro
9%
Analgesic
9%
Conditioned Place Preference
9%
Basolateral Amygdala
9%
Alternative Splicing
9%
Allodynia
8%
Exon
8%
Neurovascular Coupling
7%
Hypophysis Adenylate Cyclase Activating Polypeptide
7%
Internalization
7%
Dynorphin
7%
Nucleus Accumbens Shell
7%
Nociception
6%
Opioid Peptide
6%
Spreading Cortical Depression
6%
Circadian Rhythm
6%
Iodine-125
6%
Single-Domain Antibody
5%
Adenosine
5%
Duragesic
5%
Fentanyl
5%
Neuropathic Pain
5%
Psychotomimetic
5%
Medication Overuse
5%